AR247728A1 - Procedimiento para separar el isomero activo del cimaterol y procedimiento para preparar las sales diastereoisomeras de dicho isomero - Google Patents

Procedimiento para separar el isomero activo del cimaterol y procedimiento para preparar las sales diastereoisomeras de dicho isomero

Info

Publication number
AR247728A1
AR247728A1 AR91319603A AR31960391A AR247728A1 AR 247728 A1 AR247728 A1 AR 247728A1 AR 91319603 A AR91319603 A AR 91319603A AR 31960391 A AR31960391 A AR 31960391A AR 247728 A1 AR247728 A1 AR 247728A1
Authority
AR
Argentina
Prior art keywords
procedure
isomer
tartarico
separate
cimaterol
Prior art date
Application number
AR91319603A
Other languages
English (en)
Spanish (es)
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Application granted granted Critical
Publication of AR247728A1 publication Critical patent/AR247728A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Birds (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
AR91319603A 1990-05-04 1991-05-03 Procedimiento para separar el isomero activo del cimaterol y procedimiento para preparar las sales diastereoisomeras de dicho isomero AR247728A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014252A DE4014252A1 (de) 1990-05-04 1990-05-04 Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Publications (1)

Publication Number Publication Date
AR247728A1 true AR247728A1 (es) 1995-03-31

Family

ID=6405664

Family Applications (1)

Application Number Title Priority Date Filing Date
AR91319603A AR247728A1 (es) 1990-05-04 1991-05-03 Procedimiento para separar el isomero activo del cimaterol y procedimiento para preparar las sales diastereoisomeras de dicho isomero

Country Status (27)

Country Link
US (4) US5248695A (https=)
EP (2) EP0455155B1 (https=)
JP (1) JP2944777B2 (https=)
KR (1) KR0183024B1 (https=)
AR (1) AR247728A1 (https=)
AT (2) ATE124932T1 (https=)
AU (1) AU645313B2 (https=)
BG (1) BG60743B1 (https=)
CA (1) CA2041818C (https=)
CZ (1) CZ286389B6 (https=)
DE (3) DE4014252A1 (https=)
DK (2) DK0455155T3 (https=)
ES (2) ES2075255T3 (https=)
FI (1) FI109600B (https=)
GR (2) GR3017064T3 (https=)
HU (1) HU214335B (https=)
ID (1) ID966B (https=)
IE (2) IE69017B1 (https=)
IL (1) IL98030A (https=)
NO (1) NO174803B (https=)
NZ (1) NZ238032A (https=)
PT (1) PT97544B (https=)
RU (1) RU2002737C1 (https=)
SG (1) SG45439A1 (https=)
SK (1) SK279258B6 (https=)
TW (1) TW197415B (https=)
ZA (1) ZA913337B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
CA2247953A1 (en) * 1996-01-29 1997-07-31 E. Charles Pesterfield Jr. Method of treating undesired uterine contractions using optically pure r- or rr-isomers of adrenergic beta-2 agonists
EP1787529A3 (en) * 1997-04-30 2009-11-18 Courage Corporation Pty Ltd. Composition and methods using an eutomer
CA2286913C (en) 1997-04-30 2008-12-09 Bridge Pharma, Inc. Composition and methods using an eutomer
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
RU2201420C2 (ru) * 1998-11-03 2003-03-27 Новартис Аг Нитрилы дипептидов
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
SK15382002A3 (sk) * 2000-04-27 2003-03-04 Boehringer Ingelheim Pharma Kg Betamimetiká, farmaceutický prostriedok s ich obsahom a ich použitie
US20030162459A1 (en) * 2002-02-27 2003-08-28 Osbon Robert Lindsay Method for producing a nonwoven fabric with enhanced characteristics
US20040235922A1 (en) * 2003-05-15 2004-11-25 Baile Clifton A. Compositions and methods for inducing adipose tissue cell death
CA2526586C (en) 2003-09-09 2010-03-16 Biogen International Gmbh The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
SG124283A1 (en) * 2004-03-24 2006-08-30 Trusted Hub Ltd Document signature method & system
CN101203214B (zh) * 2005-04-13 2012-11-21 艾升制药公司 用于治疗皮肤结缔组织疾病的β2-肾上腺素受体激动剂
WO2006128180A2 (en) * 2005-05-27 2006-11-30 Children's Medical Center Corporation Methods for the treatment of disease
WO2006138243A2 (en) * 2005-06-13 2006-12-28 University Of Vermont And State Agricultural College Inhibition of creatine uptake to promote weight loss
RU2408014C2 (ru) * 2009-03-10 2010-12-27 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет им. Н.И. Пирогова Министерства здравоохранения и социального развития Российской Федерации" Способ прогнозирования преждевременных родов инфекционного генеза
DK2925725T3 (en) 2012-12-03 2017-01-16 Pfizer androgen receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136601C (https=) * 1967-06-15
US4119710A (en) * 1972-12-18 1978-10-10 Boehringer Ingelheim Gmbh Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4814350A (en) * 1986-09-10 1989-03-21 American Cyanamid Company Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)ethyl]anthranilonitrile
US4792546A (en) * 1986-12-05 1988-12-20 American Cyanamid Company Method for increasing weight gains and reducing deposition of fat in animals
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Also Published As

Publication number Publication date
IE911507A1 (en) 1991-11-06
DK0589488T3 (da) 1998-05-04
TW197415B (https=) 1993-01-01
IL98030A0 (en) 1992-06-21
DK0455155T3 (da) 1995-11-13
NZ238032A (en) 1996-02-27
EP0589488B1 (de) 1997-09-17
KR910019966A (ko) 1991-12-19
DE4014252A1 (de) 1991-11-07
US5292753A (en) 1994-03-08
HU911502D0 (en) 1991-11-28
CS129291A3 (en) 1991-11-12
IE69017B1 (en) 1996-07-24
ATE158277T1 (de) 1997-10-15
SG45439A1 (en) 1998-01-16
EP0455155B1 (de) 1995-07-12
SK279258B6 (sk) 1998-08-05
ID966B (id) 1996-09-30
FI109600B (fi) 2002-09-13
EP0589488A1 (de) 1994-03-30
ES2075255T3 (es) 1995-10-01
AU645313B2 (en) 1994-01-13
EP0455155A1 (de) 1991-11-06
IL98030A (en) 1995-12-31
ZA913337B (en) 1993-01-27
JPH04225944A (ja) 1992-08-14
AU7611191A (en) 1991-11-07
RU2002737C1 (ru) 1993-11-15
HU214335B (hu) 1998-03-02
BG94342A (en) 1994-06-30
HUT60999A (en) 1992-11-30
IE80651B1 (en) 1998-11-04
GR3025547T3 (en) 1998-03-31
JP2944777B2 (ja) 1999-09-06
NO911746L (no) 1991-11-05
ATE124932T1 (de) 1995-07-15
DE59108853D1 (de) 1997-10-23
PT97544B (pt) 1998-08-31
FI912151A0 (fi) 1991-05-03
NO911746D0 (no) 1991-05-03
US5648386A (en) 1997-07-15
BG60743B1 (bg) 1996-02-29
CA2041818A1 (en) 1991-11-05
US5395957A (en) 1995-03-07
CA2041818C (en) 2003-02-11
ES2109412T3 (es) 1998-01-16
US5248695A (en) 1993-09-28
GR3017064T3 (en) 1995-11-30
PT97544A (pt) 1992-01-31
NO174803B (no) 1994-04-05
CZ286389B6 (cs) 2000-03-15
NO174803C (https=) 1994-07-13
KR0183024B1 (ko) 1999-05-15
DE59105957D1 (de) 1995-08-17
FI912151L (fi) 1991-11-05

Similar Documents

Publication Publication Date Title
AR247728A1 (es) Procedimiento para separar el isomero activo del cimaterol y procedimiento para preparar las sales diastereoisomeras de dicho isomero
ES2150567T3 (es) Antagonistas del factor de liberacion de la corticotropina.
ES2090217T3 (es) Laca fotosensible.
CO4290349A1 (es) Procedimiento para la preparacion de propanamina asimetrica
DK0670825T3 (da) Salpetersyreestere, der har farmakologisk aktivitet, og fremgangsmåde til deres fremstilling
ES467828A1 (es) Un procedimiento para preparar nuevos compuestos de cefem y cefam
BR8302590A (pt) Derivado de alcano aromatico e processo para sua preparacao, e agentes inseticidas e acaricidas que contem o dito derivado como ingrediente ativo
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2103895T3 (es) Procedimiento para la produccion de acido graso poliinsaturado de tipo omega 9.
DE69232205D1 (de) Haarbehandlungszusammensetzung
ES2111404T3 (es) Andamio transportable.
ES2130160T3 (es) Poliesteres insaturados y membranas reticuladas de los mismos para la separacion de compuestos aromaticos/saturados.
ATE120180T1 (de) 4,5-dihydroxy und 4,5,8-trihydroxy-9,10-dioxo-2- anthracencarbonsäure-dikohlensäureester und urethane mit therapeutischer wirkung.
ES471639A1 (es) Un metodo de separacion de la 3-(3,4-dibenciloxifenil)serinadiastereoisomerica
ES2064983T3 (es) Dispositivo para el tratamiento termico y/o humectacion de carretes, canillas y conos.
ES2110000T3 (es) Procedimiento para la obtencion de los senosidos a, b, y a1.
MX9102347A (es) Composicion nematicida que contiene el compuesto 2r, 5r-dihidroximetil-3r,4r-dihidroxipirrolidina.
PT100439A (pt) Esteres de arilalquilo do acido 4,5-dihidroxi-9,10-dihidro-9,10-dioxo-2-antracenocarboxilico com actividade terapeutica
ES2126155T3 (es) Nuevos compuestos aminoesteroidales que contienen uretano.
ES2087762T3 (es) Procedimiento y medios para la participacion en un juego competitivo ilustrado y aparato para llevar a cabo dicho juego.
ES2057683T3 (es) Poliuretanos alifaticos que contienen grupos acriloilo, un procedimiento para su obtencion y su empleo.
ES2042647T3 (es) Procedimiento para la obtencion de acido adipico.
ES2058181T3 (es) Procedimiento para la obtencion de esteres del acido 5-formil-valerico.
ES8504807A1 (es) Procedimiento para preparar nuevas 4-fenil-tetrahidrofurano (2, 3-c) piridinas
ES2184150T3 (es) Uso de derivados de los acidos 7-(1-aminometil-2-oxa-7-aza-biciclo(3.3.0)oct-7il)-quinoloncarboxilico y -naftiridoncarboxilico para el tratamiento de infecciones causadas por helicobacter pylori y de las afecciones gastroduodenales asociadas con ellas.